The U.S. Department of Justice Antitrust Division ("DOJ") recently resolved a criminal case with Teva Pharmaceuticals and Glenmark Pharmaceuticals via deferred prosecution agreements ("DPAs"), which include a novel remedy for...more
9/5/2023
/ Anti-Competitive ,
Antitrust Violations ,
Bid Rigging ,
Competition ,
Corporate Counsel ,
Criminal Antitrust Litigation ,
Criminal Conspiracy ,
Criminal Investigations ,
Criminal Prosecution ,
Deferred Prosecution Agreements ,
Department of Justice (DOJ) ,
Divestiture ,
Enforcement Actions ,
Generic Drugs ,
Health Care Providers ,
Healthcare ,
Indictments ,
Life Sciences ,
Pharmaceutical Industry ,
Popular ,
Price-Fixing ,
Teva Pharmaceuticals
A Connecticut district court acquitted six defendants of criminal antitrust violations arising out of alleged employee no-poach agreements, marking the first dismissal of a U.S. Department of Justice, Antitrust Division's...more
The DOJ Antitrust Division recently announced new requirements for DOJ's Leniency Program, which allows the first individual or company to self-report its involvement in an antitrust conspiracy to avoid prosecution and lessen...more